Form 8-K - Current report:
SEC Accession No. 0001437749-13-000219
Filing Date
2013-01-04
Accepted
2013-01-04 16:59:25
Documents
3
Period of Report
2012-12-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlon20130104_8k.htm 8-K 25050
2 EXHIBIT 99.1 tlon20130104_8kex99-1.htm EX-99 10946
3 tlon20130104_8kex99-1img1.jpg GRAPHIC 4527
  Complete submission text file 0001437749-13-000219.txt   43832
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32626 | Film No.: 13512677
SIC: 2834 Pharmaceutical Preparations